|
| |
neovastat Pages on BioPortfolio:
BiotechTracker: Neovastat Trial Fails to Meet Primary Endpoint
September 25, 2003 Phase III trial results show that Aeterna’s (NASDAQ: AELA) Neovastat does not improve overall median survival time for affected ...
http://www.bioportfolio.com/news/biotracker_186.htm...
|
Biotechnology and Pharmaceutical Industry Search Find Companies ...
Neovastat activates signals that destroy fibrin provisional matrices - Cancer Therapy. NewsRxAngiogenesis: similar ... Cyclic AMP keeps transforming growth
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Neovastat as a treatment of metastatic breast cancer
Most recently Canadian researchers have shown that Neovastat inhibit ... The potential of Neovastat to retard the spread, growth, and osteolysis of ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-020210.htm...
|
New anti-angiogenic shark cartilage derivatives
One of the leading inhibitors of angiogenesis is Neovastat, a shark cartilage derivative shown to inhibit matrix metalloproteinase and VEGF signaling. ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-070210.htm...
|
BioPortfolio - AEterna Laboratories Incorporated
The company’s lead product, Neovastat®, is the focus of a number of clinical ... BACKGROUND: AE-941 (Neovastat) is an angiogenesis inhibitor noted to have. ...
http://www.bioportfolio.com/biocorporate/212-AEterna_Laborat...
|
Phase Forward Partners with Relsys International Sound Medical ...
Aeterna’s Neovastat produced disease. stabilization or improvement, in addition to. showing no dose-limiting toxicity.The trial ...
http://www.bioportfolio.com/cgi-bin/acatalog/cww-smaller.pdf...
|
BioPortfolio - Biocorporate Search Blood1
The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal trials... www.aeterna.com/ View full profile ...
http://www.bioportfolio.com/biocorporate/Blood-companies.htm...
|
Targeted Therapeutics in Non-Small Cell Lung Cancer
... Mitumomab, Neovastat, Paclitaxel, Panitumumab, Pemetrexed, Targretin, Telcyta, Tirapazamine, Trastuzumab, Vinflunine, Vinorelbine, Xcytrin, ZD-6474,
...
http://www.bioportfolio.com/cgi-bin/ss000001.pl?PRODREF=279&...
|
Competitive Outlook on Antiangiogenesis and Vascular Targeting in ...
2-methoxyestradiol, AMG-706, ATN-161, AZD-2171, bevacizumab, combretastatin A-4 prodrug, enzastaurin hydrochloride, everolimus, neovastat, PTK/ZK, ...
http://www.bioportfolio.com/cgi-bin/acatalog/Competitive_Out...
|
LeadDiscovery - Therapeutic Advances - Focus on Metastasis
Therapeutic candidates for the treatment of cancer · Neovastat as a treatment of metastatic breast cancer · Osteopontin as a target for cancer metastases ...
http://www.bioportfolio.com/LeadDiscovery/targetmetastasis.h...
|
Results from other life science and pharmaceutical sites:
Æterna Zentaris
Neovastat has also demonstrated antitumor and antimetastatic. properties. ... dence supporting the antiangiogenic activity of Neovastat ...
http://www.aeternazentaris.com/pdfdyn/Neovastat-January-2006...
|
BiotechTracker: Neovastat Trial Fails to Meet Primary Endpoint
September 25, 2003 Phase III trial results show that Aeterna’s (NASDAQ: AELA) Neovastat does not improve overall median survival time for affected ...
http://www.bioportfolio.com/news/biotracker_186.htm...
|
March 2004--Shark cartilage derivative Neovastat (AE-941) for ...
The matrix metalloproteinase inhibitor AE-941 (Neovastat®), a derivative of shark cartilage, is manufactured by Aeterna Laboratories.
http://www.naturalstandard.com/monographs/news/news200403002...
|
Neovastat (AE-941) in refractory renal cell carcin...[Ann Oncol ...
Neovastat (AE-941) is an inhibitor of angiogenesis with a mechanism of action ... The higher dose of Neovastat administered in this trial is associated with
...
http://www.ncbi.nlm.nih.gov/pubmed/12181250...
|
January 2004--Neovastat (AE-941) stimulates tissue plasminogen ...
The effects of Neovastat (AE-941) 100 microg/ml on tissue and urokinase plasminogen activator activities were investigated (1).
http://www.naturalstandard.com/monographs/news/news200401009...
|
Neovastat, a naturally occurring multifunctional antiangiogenic ...
Among the new antiangiogenic drugs in development, Neovastat (AE-941; Aeterna Laboratories, Quebec City, Canada) can be classified as a naturally occurring
...
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub...
|
Definition of shark cartilage extract AE-941 - National Cancer ...
Synonym: Neovastat/AE-941. US brand name: Neovastat. Foreign brand name: Neovastat. Code name: AE-941. Previous: Seromycin, Serophene, sertraline ...
http://www.nci.nih.gov/Templates/drugdictionary.aspx?CdrID=4...
|
Neovastat (AE-941), an inhibitor of angiogenesis: ...[J Am Acad ...
AE-941 (Neovastat; Aeterna Laboratories, Quebec City Quebec, ... Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical
...
http://www.ncbi.nlm.nih.gov/pubmed/12271297...
|
Neovastat as a treatment of metastatic breast cancer
Most recently Canadian researchers have shown that Neovastat inhibit ... The potential of Neovastat to retard the spread, growth, and osteolysis of ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-020210.htm...
|
The effect of Neovastat (AE-941) on an experimenta...[Int J Oncol ...
We showed that Neovastat prevented the degradation of osteoid-like ... The potential of Neovastat to retard the spread, growth, and osteolysis of MDA-MB-
231 ...
http://www.ncbi.nlm.nih.gov/pubmed/11788892...
|
|
